UNSPSC 51284025: Doxycycline calcium

This classification denotes a tetracycline antibiotic C22H24N2O8.2Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8ZL07I20SB, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4s-(4a,4aa,5a,5aa,6a,12aa))-, calcium salt (2:1), but more generally known as doxycycline calcium, which bears US NIH Compound Identifier 62305.

UNSPSC 51284025 Doxycycline calcium, a Commodity code, covers pharmaceutical procurement by state and local health agencies, though the recent opportunities block shows mixed alignment with the code's nominal scope. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, supplying Doxycycline Hyclate 100mg tablets in 20-count packages alongside Ciprofloxacin Hydrochloride 500mg tablets under a 12-month initial term with two renewal options. State and local purchasing under this code draws from health departments and county community health programs, with work consisting of bulk pharmaceutical supply agreements for antibiotic and emergency-response medications delivered through competitive bidding processes.

The code shows activity concentrated in Illinois and Florida. Beyond the Illinois Department of Public Health award, Seminole County, Florida posted an IFB on June 30, 2026 (due July 26, 2023) for naloxone and drug deactivation systems, though this procurement falls outside the doxycycline calcium scope. The Illinois contract represents a completed IFB award rather than an open solicitation; the Seminole County posting is outdated and not an active opportunity. No current open solicitations under this code are present in the source.